These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: fibrinogen Mannheim V. Dempfle CE, George PM, Borggrefe M, Neumaier M, Brennan SO. Thromb Haemost; 2009 Jul; 102(1):29-34. PubMed ID: 19572064 [Abstract] [Full Text] [Related]
11. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Stucki B, Zenhäusern R, Biedermann B, Baudo F, Redaelli R, Lämmle B, Furlan M. Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658 [Abstract] [Full Text] [Related]
12. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia. Xu X, Wu J, Zhai Z, Zhou R, Wang X, Wang H, Ding K, Sun Z, Ni H. Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370 [Abstract] [Full Text] [Related]
13. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia. Kotlín R, Chytilová M, Suttnar J, Riedel T, Salaj P, Blatný J, Santrůcek J, Klener P, Dyr JE. Thromb Res; 2007 Jun; 121(1):75-84. PubMed ID: 17408725 [Abstract] [Full Text] [Related]
14. A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream. Robert-Ebadi H, de Moerloose P, El Khorassani M, El Khattab M, Neerman-Arbez M. Blood Coagul Fibrinolysis; 2009 Jul; 20(5):385-7. PubMed ID: 19417632 [Abstract] [Full Text] [Related]
15. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release. Mathonnet F, Guillon L, Detruit H, Mazmanian GM, Dreyfus M, Alvarez JC, Giudicelli Y, de Mazancourt P. Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754 [Abstract] [Full Text] [Related]
16. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain. Rosenberg JB, Newman PJ, Mosesson MW, Guillin MC, Amrani DL. Thromb Haemost; 1993 Mar 01; 69(3):217-20. PubMed ID: 8470043 [Abstract] [Full Text] [Related]
18. Molecular basis of congenital afibrinogenaemia in a Dutch family. Remijn JA, van Wijk R, Nieuwenhuis HK, de Groot PG, van Solinge WW. Blood Coagul Fibrinolysis; 2003 Apr 01; 14(3):299-302. PubMed ID: 12695755 [Abstract] [Full Text] [Related]
19. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant. Yoshida N, Imaoka S, Hirata H, Matsuda M, Asakura S. Thromb Haemost; 1992 Nov 10; 68(5):534-8. PubMed ID: 1455400 [Abstract] [Full Text] [Related]
20. Hypofibrinogenemia due to novel 316 Asp --> Tyr substitution in the fibrinogen Bbeta chain. Brennan SO, Wyatt JM, May S, De Caigney S, George PM. Thromb Haemost; 2001 Mar 10; 85(3):450-3. PubMed ID: 11307813 [Abstract] [Full Text] [Related] Page: [Next] [New Search]